161 related articles for article (PubMed ID: 28589137)
21. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
22. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.
Zheng MH; Robbins P; Xu J; Huang L; Wood DJ; Papadimitriou JM
Histol Histopathol; 2001 Jan; 16(1):297-307. PubMed ID: 11193206
[TBL] [Abstract][Full Text] [Related]
23. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
[TBL] [Abstract][Full Text] [Related]
24. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.
Lou Z; Yang Y; Ren T; Tang S; Peng X; Lu Q; Sun Y; Guo W
Med Oncol; 2013; 30(3):606. PubMed ID: 23690270
[TBL] [Abstract][Full Text] [Related]
25. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
[TBL] [Abstract][Full Text] [Related]
27. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
28. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.
Kim Y; Nizami S; Goto H; Lee FY
Clin Orthop Surg; 2012 Jun; 4(2):107-16. PubMed ID: 22662295
[TBL] [Abstract][Full Text] [Related]
29. 5-Fluoruracil blocked giant cell tumor progression by suppressing osteoclastogenesis through NF-kappaB signals and blocking angiogenesis.
Song D; Meng T; Xu W; Hou T; Lin Z; Yin H; Li B; Zhou L; Wang T; Han S; Fan T; Miao W; Liu M; Luo J; Zhou W; Li Z; Xiao J
Bone; 2015 Sep; 78():46-54. PubMed ID: 25956534
[TBL] [Abstract][Full Text] [Related]
30. Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.
Smink JJ; Tunn PU; Leutz A
J Mol Med (Berl); 2012 Jan; 90(1):25-30. PubMed ID: 22071989
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-183 increases osteoclastogenesis by repressing heme oxygenase-1.
Ke K; Sul OJ; Rajasekaran M; Choi HS
Bone; 2015 Dec; 81():237-246. PubMed ID: 26163109
[TBL] [Abstract][Full Text] [Related]
32. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
Jin Y; Zhang J; Zhu H; Fan G; Zhou G
Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
[TBL] [Abstract][Full Text] [Related]
33. Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells.
Park B
Biochimie; 2014 Oct; 105():129-36. PubMed ID: 25047443
[TBL] [Abstract][Full Text] [Related]
34. Giant cell tumour of bone.
Thomas DM; Skubitz KM
Curr Opin Oncol; 2009 Jul; 21(4):338-44. PubMed ID: 19444102
[TBL] [Abstract][Full Text] [Related]
35. MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP.
Zhou W; Yin H; Wang T; Liu T; Li Z; Yan W; Song D; Chen H; Chen J; Xu W; Yang X; Wu Z; Xiao J
Bone; 2014 Sep; 66():267-76. PubMed ID: 24973691
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1α.
Yang X; Lei S; Long J; Liu X; Wu Q
Mol Med Rep; 2016 Jun; 13(6):5241-7. PubMed ID: 27122154
[TBL] [Abstract][Full Text] [Related]
37. miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways.
Gong M; Ma J; Guillemette R; Zhou M; Yang Y; Yang Y; Hock JM; Yu X
Mol Cancer Res; 2014 Jan; 12(1):101-10. PubMed ID: 23966614
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
39. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-124 regulates osteoclast differentiation.
Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
